As of Q4'25, CVS reported an ROA of 1.16%, an ROE of 3.91%, and an ROIC of 1.24%. These latest figures reflect a notable recovery from the previous quarter, where all three metrics experienced negative or significantly lower values. From Q1'23 to Q4'25, the chart shows that CVS’s profitability ratios—ROA, ROE, and ROIC—have generally exhibited volatility, with periods of both decline and recovery. After a steady performance through 2023, all three metrics dropped sharply in Q1'24, partially rebounded in mid-2024, and then faced another significant dip in Q3'25 (with ROA and ROIC turning negative). The strong rebound in Q4'25 suggests improved operational efficiency or profitability, but the overall trend indicates ongoing fluctuations and potential underlying instability in returns over the observed period.